首页>
外国专利>
CICLETANINE AND PKC INHIBITORS IN THE TREATMENT OF PULMONARY AND CARDIAC DISORDERS
CICLETANINE AND PKC INHIBITORS IN THE TREATMENT OF PULMONARY AND CARDIAC DISORDERS
展开▼
机译:西尼胆碱和PKC抑制剂在治疗肺部和心脏疾病中的作用
展开▼
页面导航
摘要
著录项
相似文献
摘要
Embodiments of the present invention are related to novel therapeutic drugs, drug combinations, and associated methods for treating or preventing pulmonary disease, including pulmonary hypertension, pulmonary fibrosis, asthma and COPD, and heart failure, together with other pulmonary and cardiovascular diseases and their complications. More particularly, aspects of the present invention are related to the use of cicletanine and ruboxistaurin as monotherapies or in combination with other agents for treatment of disease. Cicletanine may be used as pure (+) or (-) enantiomers or as a racemic or non-racemic mixture of those enantiomers.
展开▼